![Rani Therapeutics Holdings, Inc. logo](/logos/RANI.webp)
Rani Therapeutics Holdings, Inc.
NASDAQ:RANI
Overview | Financials
Company Name | Rani Therapeutics Holdings, Inc. |
Symbol | RANI |
Currency | USD |
Price | 2.62 |
Market Cap | 139,923,885 |
Dividend Yield | 0% |
52-week-range | 1.82 - 8.75 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Talat Imran |
Website | https://www.ranitherapeutics.com |
An error occurred while fetching data.
About Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD